BPC-157 (Oral) (BPC-157 Oral Formulation (Arginate Salt))
An oral-stable formulation of BPC-157 using the arginate salt form. Provides systemic healing benefits through oral administration with particular gut and organ healing properties.
How it works
Same mechanism as injectable BPC-157 but delivered orally. Upregulates VEGF, modulates NO system, and promotes gut mucosal healing through direct contact and systemic absorption.
Key facts
- Molecular weight: 1419.53 Da
- Half-life: ~4 hours (oral bioavailability lower but sustained)
- Bioavailability: ~40-60% oral (arginate salt form)
- Storage: Room temperature, sealed container. Protect from moisture.
Dosing overview
- Typical dose: 500 mcg - 1 mg
- Frequency: 1-2x daily
- Duration: 4-12 weeks
- Route: Oral capsule (arginate salt)
Reported benefits
- Gut healing (direct contact)
- Liver protection
- Oral convenience
- Systemic anti-inflammatory
- No injection required
Possible side effects
- Mild nausea
- GI discomfort initially
- Lower potency than injectable
Research
- Oral BPC-157 in NSAID-induced gut damage (2020): Oral administration prevented and reversed NSAID-induced gastric and intestinal lesions in rat models.
- Stable gastric pentadecapeptide oral bioavailability (2019): Arginate salt form maintained 45% bioavailability with preserved biological activity orally.
Compare BPC-157 (Oral)
Research and educational reference only. Not medical advice.